Bill · H.R. 1922· House(119-HR-1922)
Ensuring Access to Essential Drugs Act
- Introduced
- 3/6/2025
- Last activity
- 3/6/2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsored by
- Andrew Garbarino
- Cosponsors
- - 1 - 1
- Introduced
- In Committee
What this bill would do
This bill, titled the "Ensuring Access to Essential Drugs Act," seeks to amend title XVIII of the Social Security Act. It focuses on exempting specific drugs from the part D manufacturer discount program within the Medicare program. The amendment specifically addresses orally administered drugs that have received a new drug application approval. Additionally, it targets drugs granted a narrow exception for reclassification as a noninnovator multiple source drug.
Yes
No question was scored yes.
The opposite· 3 of 5
Does this lower the price of prescription medicines?-3
Exempting certain drugs from the manufacturer discount program could potentially reduce the savings achieved on drug costs for Medicare beneficiaries.
Would people over 65 be better off under this?-2
The exemption from manufacturer discounts may lead to higher out-of-pocket costs for seniors on Medicare.
Would households on low incomes be better off under this?-2
Potential increases in drug costs could disproportionately affect low-income households relying on Medicare.
Who it would affect, and how
Potential Positive Impacts for People
- Exemption for specific oral drugs: The bill adds a new subparagraph to exempt certain orally administered drugs from the part D manufacturer discount program. This applies to drugs with a new drug application approved under section 505 of the Federal Food, Drug, and Cosmetic Act that have also been granted a narrow exception for reclassification as a noninnovator multiple source drug by the Centers for Medicare & Medicaid Services. (Section 2)
Potential Negative Impacts for People
- No negative impacts are mentioned: The provided text does not contain any information regarding potential negative consequences or burdens resulting from this bill.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Low Income Households-2Good For Retirees-2Good For Seniors-2
- Healthcare
- Reduces Prescription Drug Costs-3
- Economy And Finance
- Reduces Government Spending-2
- 3/6/2025
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2 Cosponsors added.
- Introduced in House
Diana HarshbargerRepublican · Tennessee
Thomas SuozziDemocrat · New York